Patents by Inventor Mauricio Redondo-Müller

Mauricio Redondo-Müller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of anti-FGFR4-antibody and bile acid sequestrant
    Patent number: 11648310
    Abstract: The present invention relates to the amelioration of toxic effects that are caused by therapies aimed at FGFR4-inhibition. In particular, the invention relates to the combination of FGFR4 inhibitors and agents capable of reducing bile acid levels and to the use thereof in the treatment of diseases.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: May 16, 2023
    Inventors: Reimar Abraham, Mauricio Redondo-Müller
  • COMBINATION OF ANTI-FGFR4-ANTIBODY AND BILE ACID SEQUESTRANT
    Publication number: 20210023211
    Abstract: The present invention relates to the amelioration of toxic effects that are caused by therapies aimed at FGFR4-inhibition. In particular, the invention relates to the combination of FGFR4 inhibitors and agents capable of reducing bile acid levels and to the use thereof in the treatment of diseases.
    Type: Application
    Filed: July 22, 2020
    Publication date: January 28, 2021
    Inventors: Reimar Abraham, Mauricio Redondo-Müller
  • Combination of anti-FGFR4-antibody and bile acid sequestrant
    Patent number: 10765738
    Abstract: The present invention relates to the amelioration of toxic effects that are caused by therapies aimed at FGFR4-inhibition. In particular, the invention relates to the combination of FGFR4 inhibitors and agents capable of reducing bile acid levels and to the use thereof in the treatment of diseases.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: September 8, 2020
    Assignees: Daiichi Sankyo Europe GmbH, Daiichi Sankyo Company Limited
    Inventors: Reimar Abraham, Mauricio Redondo-Müller
  • COMBINATION OF ANTI-FGFR4-ANTIBODY AND BILE ACID SEQUESTRANT
    Publication number: 20180133312
    Abstract: The present invention relates to the amelioration of toxic effects that are caused by therapies aimed at FGFR4-inhibition. In particular, the invention relates to the combination of FGFR4 inhibitors and agents capable of reducing bile acid levels and to the use thereof in the treatment of diseases.
    Type: Application
    Filed: May 18, 2016
    Publication date: May 17, 2018
    Inventors: Reimar Abraham, Mauricio Redondo-Müller